SCHEMBL18177841

SCHEMBL18177841

CC(C)(C)C(=O)Nc1ccccc1C(=O)NCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.65
KDM4E B2RXH2 3/20 0.65
MEN1 O00255 2/20 0.65
ALDH1A1 P00352 2/20 0.61
HTT P42858 1/20 0.61
MMP8 P22894 1/20 0.56
MT-CO2 P00403 1/20 0.56
CFD P00746 1/20 0.55
ITGA4 P13612 1/20 0.54
ITGB7 P26010 1/20 0.54
GAA P10253 3/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TP53 P04637 1/20 0.54
GLA P06280 1/20 0.54
APEX1 P27695 1/20 0.53
METAP2 P50579 1/20 0.52
CHRNB2 P17787 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18181886 0.84 KDM4E (0.70) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL1671881 0.82 TSHR (0.59) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL6098448 0.81 KDM4E (0.67) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL13932577 0.80 KDM4E (0.65) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL14855551 0.79 KMT2A (0.64) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL20715526 0.79 HSD17B10 (0.54) KDM4EALDH1A1MMP8GAAHPGD
SCHEMBL3994998 0.78 CETP (0.59) KMT2AKDM4EMEN1ALDH1A1LMNA
SCHEMBL6097529 0.78 MMP8 (0.63) KMT2AKDM4EMEN1ALDH1A1HTT
SCHEMBL1516186 0.78 RIPK1 (0.71) KMT2AMEN1ALDH1A1MMP8GAA
SCHEMBL11901003 0.78 KMT2A (0.89) KMT2AGAAHPGDLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage WASE, NISHIKANT 2020-03-05 US disclosed
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 KMT2A 2512/4885KDM4E 1755/4885MEN1 2824/4885
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 KMT2A 2512/4885KDM4E 1755/4885MEN1 2824/4885
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 KMT2A 2512/4885KDM4E 1755/4885MEN1 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.